Roche Says Counterfeit Cancer Drug Avastin Being Investigated by U.S. FDA
Roche Holding AG is working with U.S. authorities to determine the source of counterfeit Avastin, purchased by at least 19 medical practices in the U.S.
Malgré un environnement réglementé, la contrefaçon sévit même dans les pays industrialisés.
Reactions
(4)
No comment yet.
Sign up to comment